Bristol Myers Squibb (BMY)

Stock-Based Compensation

$135.00M

Quarterly · Period ending: · USD

BMY logo

BMY Stock-Based Compensation

Latest reported$135.00M
BMY Quarterly Stock-Based Comp ($0.00 → $135.00M)
High-resolution chart · PNG

BMY stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
135,000,000
146,000,000
133,000,000
139,000,000
137,000,000
144,000,000
120,000,000
129,000,000
125,000,000
133,000,000
127,000,000
132,000,000
137,000,000
122,000,000
119,000,000
115,000,000
116,000,000
107,000,000
133,000,000
142,000,000
157,000,000
151,000,000
171,000,000
185,000,000
213,000,000
210,000,000
284,000,000
56,000,000
48,000,000
53,000,000
53,000,000
62,000,000
51,000,000
55,000,000
50,000,000
50,000,000
54,000,000
45,000,000
56,000,000
48,000,000
54,000,000
47,000,000
59,000,000
63,000,000
59,000,000
54,000,000
66,000,000
48,000,000
50,000,000
49,000,000
51,000,000
45,000,000
46,000,000
49,000,000
46,000,000
26,000,000
40,000,000
42,000,000
41,000,000
39,000,000
43,000,000
38,000,000
50,000,000
47,000,000
49,000,000
47,000,000
53,000,000
42,000,000
45,000,000
43,000,000
0
0
40,000,000
48,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.